{"disease":{"id":"achromatopsia","name":"achromatopsia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07085533","title":"Natural History Study of Inherited Retinal Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Zhongmou Therapeutics","has_results":false},{"nct_id":"NCT04124185","title":"Natural History Study for Achromatopsia","phase":"","overall_status":"COMPLETED","enrollment_count":85,"lead_sponsor_name":"MeiraGTx UK II Ltd","has_results":false},{"nct_id":"NCT03278873","title":"Long-Term Follow-Up Gene Therapy Study for Achromatopsia CNGB3 and CNGA3","phase":"","overall_status":"TERMINATED","enrollment_count":34,"lead_sponsor_name":"MeiraGTx UK II Ltd","has_results":true},{"nct_id":"NCT03001310","title":"Gene Therapy for Achromatopsia (CNGB3)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"MeiraGTx UK II Ltd","has_results":true},{"nct_id":"NCT03758404","title":"Gene Therapy for Achromatopsia (CNGA3)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"MeiraGTx UK II Ltd","has_results":true}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}